Trials
Search / Trial NCT05661695

Evaluation of Clinical Tool to Improve Adherence to Ventilator Management at UM

Launched by CONVERGENT ENGINEERING, INC. · Dec 14, 2022

Trial Information

Current as of January 21, 2025

Not yet recruiting

Keywords

ClinConnect Summary

Background:

Respiratory Therapists (RTs) face challenges to provide high quality patient care including maintaining compliance with evidence-based practice protocols using lung protective ventilation (LPV) (tidal volume \[VT\] 4 to 8 ml predicted body weight and plateau pressure \[Pplt\] \< 30 cm H2O), efficient communication during patient handoffs at shift changes and maintaining situational awareness amidst a high patient-to-clinician ratio and elevated acuity of patient care. Lung-protective ventilation (LPV) guidelines, initially published by ARDS Net and supported by the American Tho...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Practicing RTs are eligible to participate in this study
  • Exclusion Criteria:
  • non-RTs or those who refuse to participate

About Convergent Engineering, Inc.

Convergent Engineering, Inc. is a pioneering clinical trial sponsor dedicated to advancing medical research through innovative engineering solutions. With a focus on integrating cutting-edge technology and data analytics, the company aims to enhance the efficiency and effectiveness of clinical trials across various therapeutic areas. Leveraging a multidisciplinary team of experts, Convergent Engineering collaborates with pharmaceutical companies, research institutions, and healthcare providers to streamline trial design and execution, ensuring robust data collection and regulatory compliance. Committed to improving patient outcomes, the company strives to facilitate the development of safe and effective therapies, ultimately contributing to the advancement of healthcare.

Locations

Miami, Florida, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials